Chief Accounting Officer
CytoDyn Inc. (CYDY)Equibles does not estimate personal net worth.
Mitchell Cohen is recorded as CFO and Chief Accounting Officer at CytoDyn Inc. (CYDY) since February 1, 2024. CytoDyn Inc. reported in an 8-K filed May 6, 2025 that Mitchell Cohen resigned as interim Chief Financial Officer, effective May 12, 2025. CytoDyn Inc. reported in an 8-K filed January 29, 2024 that Mitchell Cohen was appointed Interim CFO, effective February 1, 2024. CytoDyn Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at CytoDyn Inc. includes Dr. Jacob P. Lalezari (CEO), Jacob P. Lalezari (CEO), Jacob P. Lalezari, M.D. (CEO) and 7 others.
“On May 2, 2025, the Company and Mr. Cohen, the Company's interim Chief Financial Officer, agreed that Mr. Cohen will resign from his position as CFO of the Company, effective May 12, 2025, and that his last day of employment with the Company will be May 30, 2025.”
“On January 10, 2024, the Company entered into an agreement with Rapid Deployment LLC d/b/a InterimExecs ("InterimExecs"), under which Mitchell Cohen will serve as the Company's Interim CFO, effective February 1, 2024 (the "Interim Services Agreement").”
2024-02-01–present
2024-02-01–present
2024-02-01–2025-05-12
Start not stated–2025-05-12
CYDY
Biotechnology · Healthcare
CFO, Chief Accounting Officer
2024-02-01–present
